Descriptor
Source
| American Journal on Mental… | 7 |
Author
Publication Type
| Journal Articles | 7 |
| Reports - Research | 3 |
| Information Analyses | 2 |
| Opinion Papers | 2 |
| Guides - Non-Classroom | 1 |
| Tests/Questionnaires | 1 |
Education Level
Audience
| Researchers | 1 |
Location
Laws, Policies, & Programs
Assessments and Surveys
What Works Clearinghouse Rating
Sandman, Curt A.; And Others – American Journal on Mental Retardation, 1990
Four adults with severe/profound mental retardation and self-injurious behavior (SIB) received naltrexone in a double-blind procedure. All patients exhibited decreased SIB when treated with naltrexone; three patients decreased SIB as naltrexone dose increased. There were no consistent effects of naltrexone on stereotypy, activity, or performance…
Descriptors: Behavior Change, Behavior Disorders, Drug Therapy, Pharmacology
Schaal, David W.; Hackenberg, Timothy – American Journal on Mental Retardation, 1994
A review of the use of psychotropic medications for people with developmental disabilities is presented. Results suggest that prescribing drugs based on topographical features of the problem behavior, without considering the function the behavior serves for the individual, contributes to variability in clinical response. Functional analysis of a…
Descriptors: Behavior Change, Behavior Disorders, Behavior Patterns, Behavior Problems
Zarcone, Jennifer R.; Hellings, Jessica A.; Schroeder, Stephen R. – American Journal on Mental Retardation, 2003
The author of a paper on effects of risperidone on behavior in people with developmental disabilities rebuts a criticism by suggesting that a specific diagnosis of psychiatric disorder is unimportant, since risperidone was effective in reducing aberrant behavior regardless of psychiatric diagnosis and/or environmental contingencies. (Contains…
Descriptors: Adult Education, Behavior Change, Behavior Disorders, Clinical Diagnosis
Friedman, Debra L.; And Others – American Journal on Mental Retardation, 1992
This study with 65 individuals with mental retardation and additional seizure and/or psychiatric or behavioral disorders found that 9.2 percent experienced medication (carbamazepine) side effects, ranging from irritability to mania. More side effects were experienced by individuals with behavioral or psychiatric disorders than by those with an…
Descriptors: Behavior Change, Behavior Disorders, Behavior Problems, Drug Therapy
Levitas, Andrew – American Journal on Mental Retardation, 2003
In response to a paper on effects of risperidone on behavior in people with developmental disabilities, this paper raises the issue of how clinicians determine whether treatment should target the psychiatric disorder underlying the aberrant behavior (diagnosis-based treatment) or should target the aberrant behavior directly (behavior-based…
Descriptors: Adult Education, Behavior Change, Behavior Disorders, Clinical Diagnosis
Mudford, Oliver C. – American Journal on Mental Retardation, 1995
Review of claims for the effectiveness of the gentle teaching philosophy with people having severe problem behaviors and mental retardation finds that the methods were unsuccessful with seven of nine individuals. Although more research is needed, the review suggests that gentle teaching cannot be considered an ethically defensible treatment…
Descriptors: Behavior Change, Behavior Disorders, Educational Methods, Educational Philosophy
McAdam, David B.; Zarcone, Jennifer R.; Hellings, Jessica; Napolitano, Deborah A.; Schroeder, Stephen R. – American Journal on Mental Retardation, 2002
Consumer satisfaction and social validity were measured during a double-blind, placebo-controlled evaluation of risperidone in treating aberrant behaviors of persons with developmental disabilities. A survey showed all 17 caregivers felt participation was positive. Community members (n=52) also indicated that when on medication, the 5 participants…
Descriptors: Adolescents, Adults, Behavior Change, Behavior Disorders
